Cardio: RAAS Drugs Flashcards
- Drugs that:
- Prevent the formation of Angiontensin II
- Prevent degredation of bradykinin
ACE Inhibitors: (“-PRIL”)
Lisinopril
Captopril
Enalapril
Clinical use of ACE inhibitors:
- HTN
- CHF
- HCM
- MI
- Renal failure and fibrosis
- Diabetes
Contraindications for ACE inhibitors and ARBs:
- Renal artery stenosis → Renal Failure
- Elevated serum K+ (>5.5 mEq/L)
- Symptomatic hypotension
-
Pregnancy (chronic mgmt of Hypertension)
- Methyldopa
- Hydralazine
Side effects of ACE inhibitors and ARBs:
- Severe hypotension
- Chronic nonproductive dry cough (ACEs)
- Dysgeusia (altered taste)
- Renal hemodynamic dysfunction
- Renal Artery Stenosis (contraindicated)
→ Renal Failure
- Renal Artery Stenosis (contraindicated)
- Hyperkalemia (Lack of Aldosterone)
- Angioedema (rare)
- Drugs that:
- Nonpeptide AT1 receptor antagonism that interferes w/ binding of Angiotensin II to its receptor
- DOES NOT effect the breakdown of bradykinin
ARBs (AT1 receptor blockers) (“-SARTAN”)
Losartan
Vaisartan
Clinical use of ARBs:
- HTN
- CHF
Aldosterone receptor antagonist drugs:
- Spironolactone
- Aldosterone receptor antagonist
- Eplerenone (Inspa)
- Selective aldosterone receptor blocker
Mechanism of action for Aldosterone antagonists:
- Aldosterone (a mineralocorticoid hormone) produced in the adrenal cortex and in extra-adrenal sites) whose synthesis and secretion are affected by Angiotensin II, plasma potassium levels, ACTH, and other stimuli
- Angiotensin II is the most potent stimulus
- Kidney: stimulates sodium retention by distal nephrons, potassium excretion, blood volume expansion, elevation of blood pressure
- Other sites: increases blood pressure by a CNS mechanism, stimulates myocardial fibrosis, reduces arterial elasticity and increases inflammation
Clinical use of Aldosterone receptor antagonists:
- Hypertension
- CHF
Contraindications of Aldosterone antagonists:
- Hyperkalemia
- Cirrhosis
Side effects of Aldosterone antagonists:
- Hyperkalemia (both drugs)
- Progestational and antiandrogenic side effects (Spironolactone only):
- Gynecomastia
- Impotence
- Menstrual irregularities
- Increases kidney tubular fluid osmolarity - pulls water from the interstial space into the tubules via osmosis - more water is excreted into the urine and less water reabsorbed into the ciruclation
- Acts on the Proximal tubule
- Tx: Intracranial Pressure, Increased Ocular Pressure
- Can pull fluid into the blood and lead to Hypervolemia –> which can lead to peripheral and pulmonary edema
Mannitol
Drug acts on the Proximal Convoluted Tubule
Acetazolamide and Osmotic Agents (Mannitol)
Drug acts on the Descending Limb
Osmotic agents (Mannitol)
Drug acts on the Thick Ascending Limb
Loop Diuretic Agents (Furosemide)
Ethacrynic acid
Drug acts on the Distal Convoluted Tubule
Loop Agents (Furosemide)
Thiazides
Aldoesterone antagonists
Drug acts on the Collecting Duct
ADH antagonists
Osmotic agents (Mannitol)
- Prevents the conversion of HCO3- into CO2 by carbonic anhydrase primarily at the brush border of the proximal tubule cells, necessary for the reabsorption of HCO3-
- Proximal convouted tubule
- Tx: Metabolic alkalosis, Altitude sickness, Glaucoma, or Intracranial HTN (Pseudotumor cerebri)
- SEx: Metabolic acidosis due to HCO3-, urine pH goes up, blood pH goes down, also allergic rxns to sulfa group
Acetazolamide
- Inhibits Na+ K+ 2Cl- channel in the thick ascending limb of the loop of Henle - Loop diuretics - OH DANG!
- Na+ and K+ abolish the Hypertonicity of the Medulla (urine cannot be collected in the collecting ducts)
- Marked diuresis –> Ca2+ excretion
- Tx: Edema (CHF, Cirrhosis, Nephrotic syndrome, PE), moderate to severe HTN, Acute ion overdose, and Hypercalcemia
- SEx: Azotemia, Ototoxicity, Hyponatremia, Hypokalemia, Hypercalciuria, Hypocalcemia, Dehydration, Allergy to sulfa (furosemide, not ethacrynic acid), Nephritis, Gout
Furosemide (Lasix)
Ethacrynic acid (Edecrin)
Bumetanide (Bumex)
OH DANG!
- Ototoxicity
- Hypokalemia, Hypercalcuria
- Dehydration
- Allergy to sulfa (Furosemide)
- Nephritis
- Gout
- Thiazide diuretics
- Inhibit Na+, Cl- co-transporter, which blocks the reabsorption of Na+ and Cl- in the **Distal Convoluted Tubule - **competing for the Cl- site
- NaCl is excreted along with water into the urine –> increases Ca2+ reabsorption
- Action is addivitve to Ethacrynic acid and Furosemide
- Tx: Mild to moderate HTN, mild CHF, Nephrogenic diabetes insipidus, Idiopathic Hypercalcuria
- SEx: Hyperglycemia, Hyperlipidemia, Hyperuricemia, Hypercalcemia, Sulfa allergy - HyperGLUC
Hydrochlorothiazide
Chlorothiazide
Metolazone
- HyperGLUC
- HyperGlycemia
- HyperLipidemia
- HyperUricemia
- HyperCalcemia
- Competitive antagonist at the Aldosterone receptor in the Collecting tubule (indirectly inhibits Na+) reabsorption (1st)
- Directly blocks Na+ channels in the Collecting tubule (2&3)
- K+ sparing properties:
- Less K+ secretion occurs due to inhibiton of Na+ reabsorption in the Distal Tubule (Na+ reabsorption and K+ secretion are coupled in this segment of the nephron) –> they do not greatly increase flow
- Tx: Prevents K+ waisting w/ other diuretics, CHF
- SEx: Hyperkalemia, Spironolactone causes Gynecomastia
Spironolactone
Triamterene
Amiloride
- Centrally acting sympatholytics
- Selective α2-agonist - Brain stem - reduces cental sympathetic outflow - decreased CO and SVR
- BP = CO x SVR
- Drug of choice for Hypertension in Pregnant patients
- SEx:
- M: Sedation, Positive Coombs test in 10% of patients (reversible upon discontinuation of drug)
- C: Sedation, Dry mouth, Severe rebound Hypertension with abrubt discontinuation
Methyldopa
Clonidine
- Selective** α1-receptor antagonist**; α1-blockade decreases SVR by preventing arteriolar vasoconstriction - decreased BP
- Primarily α1-receptors on arterioles, Bladder sphincter
- Tx: Mild to Mod HTN, and BPH - α1-blockers to treat urinary hesitancy for pts. w/ benign prostatic Hypertrophy (preventing bladder sphincter contraction)
- SEx: First-dose syncope orthostatic hypotension, Reflex tachycardia, Secondary Na+ retention in Kidney (use w/ diuretic), Urinary incontinence
Prazosin
α1-receptor blocker - ends in ‘osin
Doxazosin
Terazosin
- β-receptor blockers (ANS, decrease Renin release))
- Reduce HR, Contractility, Inhibit Renin
- β1-receptors on heart and kidney, β2-receptors on arterioles
- Tx: HTN, Angina, Pts. w/ previous MI, CHF
- SEx: Asthma (Bronchoconstriction (β2)), Vasospastic, Bradycardia, Blunted response to hypoglycemia - dangerous in Diabetics (masks Hypoglycemic events) on insulin therapy, **Sexual dysfunction, **small increase in LDLs and TGs
Propranolol
Carvedilol
Metoprolol
Esmolol
Atenolol
Tinolol
Drug that blocks the production of Renin:
Aliskiren
Prevents the conversion of:
Angiotensinogen → Angiotensin I